Structural basis for cooperative binding of azoles to CYP2E1 as interpreted through guided molecular dynamics simulations.
CYP2E1 metabolizes a wide array of small, hydrophobic molecules, resulting in their detoxification or activation into carcinogens through Michaelis-Menten as well as cooperative mechanisms. Nevertheless, the molecular determinants for CYP2E1 specificity and metabolic efficiency toward these compounds are still unknown. Herein, we employed computational docking studies coupled to molecular dynamics simulations to provide a critical perspective for understanding a structural basis for cooperativity observed for an array of azoles from our previous binding and catalytic studies (Hartman et al., 2014). The resulting 28 CYP2E1 complexes in this study revealed a common passageway for azoles that included a hydrophobic steric barrier causing a pause in movement toward the active site. The entrance to the active site acted like a second sieve to restrict access to the inner chamber. Collectively, these interactions impacted the final orientation of azoles reaching the active site and hence could explain differences in their biochemical properties observed in our previous studies, such as the consequences of methylation at position 5 of the azole ring. The association of a second azole demonstrated significant differences in interactions stabilizing the bound complex than observed for the first binding event. Intermolecular interactions occurred between the two azoles as well as CYP2E1 residue side chains and backbone and involved both hydrophobic contacts and hydrogen bonds. The relative importance of these interactions depended on the structure of the respective azoles indicating the absence of specific defining criteria for binding unlike the well-characterized dominant role of hydrophobicity in active site binding. Consequently, the structure activity relationships described here and elsewhere are necessary to more accurately identify factors impacting the observation and significance of cooperativity in CYP2E1 binding and catalysis toward drugs, dietary compounds, and pollutants.
['Levy|Joseph W|JW|', 'Hartman|Jessica H|JH|', 'Perry|Martin D|MD|', 'Miller|Grover P|GP|']
D000595:Amino Acid Sequence D000818:Animals D001393:Azoles D020134:Catalytic Domain D019392:Cytochrome P-450 CYP2E1 D065607:Cytochrome P-450 Enzyme Inhibitors D015195:Drug Design D006860:Hydrogen Bonding D057927:Hydrophobic and Hydrophilic Interactions D007700:Kinetics D008024:Ligands D062105:Molecular Docking Simulation D056004:Molecular Dynamics Simulation D008969:Molecular Sequence Data D011485:Protein Binding D011817:Rabbits D055672:Static Electricity D013329:Structure-Activity Relationship D013816:Thermodynamics
Azole Molecular dynamics Docking Structure activity relationships Allostery Cytochrome P450